Cancer Research and Treatment10.4143/crt.2018.1912019512611-622Comparison of Efficacy of Pembrolizumab between Epstein-Barr Virus‒Positive and ‒Negative Relapsed or Refractory Non-Hodgkin LymphomasSeok-Jin Kim, Jiyeon Hyeon, Inju Cho, Young Hyeh Ko, Won Seog Kim,,
Haematologica10.3324/haematol.2021.2783012021A phase II study of brentuximab vedotin in patients with relapsed or refractory Epstein-Barr virus-positive and CD30-positive lymphomasMiso Kim, Jeong-Ok Lee, Jiwon Koh, Tae Min Kim, Ji Yun Lee, Yoon Kyung Jeon, Bhumsuk Keam, Dong-Wan Kim, Jong Seok Lee, Dae Seog Heo,
Reactions Weekly10.1007/s40278-020-85104-420201828128-28Alemtuzumab/fludarabine,,
Histopathology10.1046/j.1365-2559.2000.00843.x2000363252-261Epstein-Barr virus and gastric carcinoma in Western patients: comparison of pathological parameters and p53 expression in EBV-positive and negative tumours Chapel, Fabiani, Davi, Raphael, Tepper, Champault, Guettier,,
Comparative Clinical Pathology10.1007/s00580-007-0710-22008172125-131Prognostic significance of cyclooxygenase-2 expression in pediatric Hodgkin and non-Hodgkin lymphomas with or without Epstein–Barr virus latent infectionSafiye Aktaş, Aydanur Kargı, Nur Olgun, Gulden Diniz, Ayşe Erbay, Canan Vergin,,
Histopathology10.1111/j.1365-2559.2011.03905.x2011592352-355Synchronous Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly and Epstein-Barr virus-positive classical Hodgkin lymphomaYu-Yan Hwang, Anskar Y H Leung, Wing-Hung Lau, Florence Loong, Jason C C So, Eric Tse, Yok-Lam Kwong,
OncoTargets and Therapy10.2147/ott.s340552014865Pixantrone for the treatment of adult patients with relapsed or refractory aggressive non-Hodgkin B-cell lymphomasStefano Volpetti, Renato Fanin, Francesco Zaja
The Lancet Oncology10.1016/s1470-2045(21)00251-52021226e234Pembrolizumab for relapsed or refractory Hodgkin lymphomaAlessandro Pulsoni,
Reactions Weekly10.1007/s40278-019-68797-820191773140-40Antineoplastics/immunosuppressants,,
Medical Microbiology and Immunology10.1007/bf0019389919871763Antibodies to the second Epstein-Barr virus nuclear antigen in non-Hodgkin lymphomasL. Gergely, J. Czegl�dy, L. V�czi, K. P�l�czi, G. Szegedi,,